Brief: CF Pharmtech Expects 2025 Revenue Of Rmb410 Million-Rmb450 Million
20/03/2026 15:28
March 20 (Reuters) - CF PharmTech Inc 2652.HK: EXPECTS 2025 REVENUE OF RMB410 MILLION-RMB450 MILLION EXPECTS 2025 NET PROFIT ATTRIBUTABLE OF RMB2 MILLION-RMB3 MILLION UNDER IFRS EXPECTED RESULT DUE REDUCTION IN AVERAGE SELLING PRICE OF GROUP'S PRODUCT CF017, OTHERS IN FY Further company coverage: 2652.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on CF PharmTech
See all newsBrief: CF Pharmtech Receives NMPA Implied Clinical Trial Approvals For ICF001 In IPF And PPF
Brief: CF Pharmtech To Place 21.7 MLN New H Shares At HK$13.82 Per Share
Brief: CF Pharmtech Says Nmpa Approves Ind Application For ICF004 As Class 1 New Drug
Brief: CF Pharmtech Inc To Nominate Zhang Jingjing As Candidate For Executive Director
CF PharmTech climbs most in 4 weeks on product marketing application in Asia